107 related articles for article (PubMed ID: 16091732)
1. Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy.
Smakman N; Veenendaal LM; van Diest P; Bos R; Offringa R; Borel Rinkes IH; Kranenburg O
Oncogene; 2005 Dec; 24(56):8338-42. PubMed ID: 16091732
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
Smakman N; Kranenburg O; Vogten JM; Bloemendaal AL; van Diest P; Borel Rinkes IH
Clin Cancer Res; 2005 Jan; 11(1):41-8. PubMed ID: 15671526
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression promotes reovirus therapy of colorectal liver metastases.
Smakman N; van der Bilt JD; van den Wollenberg DJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
Cancer Gene Ther; 2006 Aug; 13(8):815-8. PubMed ID: 16543920
[TBL] [Abstract][Full Text] [Related]
4. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
5. KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.
Smakman N; van den Wollenberg DJ; Elias SG; Sasazuki T; Shirasawa S; Hoeben RC; Borel Rinkes IH; Kranenburg O
Cancer Res; 2006 May; 66(10):5403-8. PubMed ID: 16707468
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA
Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105
[TBL] [Abstract][Full Text] [Related]
7. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of K-ras gene mutation in colorectal cancer].
Cerottini JP; Givel JC; Benhattar J
Swiss Surg; 1995; (6):304-6. PubMed ID: 8581817
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line.
Liu L; Zhang Q; Zhang Y; Wang S; Ding Y
Neoplasia; 2006 Nov; 8(11):917-24. PubMed ID: 17132223
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
13. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
[TBL] [Abstract][Full Text] [Related]
14. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
[TBL] [Abstract][Full Text] [Related]
15. Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers.
Arena S; Isella C; Martini M; de Marco A; Medico E; Bardelli A
Cancer Res; 2007 Sep; 67(18):8468-76. PubMed ID: 17875685
[TBL] [Abstract][Full Text] [Related]
16. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
17. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
[TBL] [Abstract][Full Text] [Related]
18. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
[TBL] [Abstract][Full Text] [Related]
19. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
Clark CE; Beatty GL; Vonderheide RH
Cancer Lett; 2009 Jun; 279(1):1-7. PubMed ID: 19013709
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
